Menu
Annual · values202520242023202220212020
Operating Cash Flow-12.44 M USD-9.13 M USD5.24 M USD-13.53 M USD-2.18 M USD5.13 M USD
Depreciation & Amortization0 USD5000 USD
Stock-Based Compensation6.29 M USD6.10 M USD2.61 M USD4.42 M USD2.47 M USD153000 USD
Capital Expenditures15.00 M USD5.00 M USD20.00 M USD
Cash Flow from Investing-15.00 M USD-5.00 M USD-20.00 M USD-10.00 M USD-1.20 M USD
Cash Flow from Financing16.23 M USD16.99 M USD-4.80 M USD16.46 M USD53.02 M USD-487000 USD
Dividends Paid
Stock Buybacks
Free Cash Flow-24.13 M USD240000 USD-33.53 M USD

Journey Medical Corp is an esteemed biopharmaceutical company focused on the dermatological sector. Its primary function is to develop and commercialize innovative pharmaceutical products that address the unmet medical needs in dermatology. Journey Medical Corp's portfolio includes a wide range of dermatological products designed to treat various conditions, including acne, rosacea, and other skin disorders. The company's emphasis on dermatology allows it to significantly impact the healthcare industry by providing critical treatments that enhance patient care and outcomes. As a player in the biopharmaceutical market, Journey Medical Corp contributes to advancing medical research and development, particularly in skin care solutions. This focus not only enhances its importance in the healthcare sector but also emphasizes the growing need for specialized therapies in dermatology, underscoring its role in improving the quality of life for patients suffering from chronic skin conditions.